INCREASED LONG-TERM CANCER RISK IN AUTOIMMUNE HEPATITIS (AIH): RELATION TO IMMUNOSUPPRESSIVE DRUG TREATMENT

被引：3
|
作者：
Hoeroldt, B. S. [1 ,2 ]
Gleeson, D. [1 ]
Shephard, K. [1 ]
Farquarson, N. [1 ]
MacFarlane, E. [1 ]
Karajeh, M. [1 ]
Poole, J. [2 ]
机构：
[1] Sheffield Teaching Hosp, Hepatol, Sheffield, S Yorkshire, England
[2] Canc Registry, Canc Registry Yorkshire & Humber, Sheffield, S Yorkshire, England
来源：
GUT | 2016年 / 65卷
关键词：
D O I：
10.1136/gutjnl-2016-312388.162
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PTU-077
引用
收藏
页码：A91 / A92
页数：2
相关论文
共 50 条
  • [31] AZATHIOPRINE FOR LONG-TERM MAINTENANCE OF REMISSION IN AUTOIMMUNE HEPATITIS
    JOHNSON, PJ
    MCFARLANE, IG
    WILLIAMS, R
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (15): : 958 - 963
  • [32] Hydroxychloroquine as an adjuvant drug to immunosuppressive treatment to achieve histological remission in autoimmune hepatitis
    Evangelista, Andreia
    Terrabuio, Debora Raquel
    Vilar Guedes, Ana Luiza
    Moreto, Amanda
    Cancado, Eduardo
    JOURNAL OF HEPATOLOGY, 2024, 80 : S343 - S343
  • [33] Development and validation of a novel risk score predicting long-term survival in autoimmune hepatitis
    Biewenga, Maaike
    Xavier, Verhelst
    Baven-Pronk, Martine
    Putter, Hein
    van den Berg, Aad
    van Nieuwkerk, Karin
    Van Buuren, Henk
    Bouma, Gerd
    de Boer, Ynte
    Simoen, Cedric
    Colle, Isabelle
    Schouten, Jeoffrey
    Sermon, Filip
    Van Steenkiste, Christophe
    Van Vlierberghe, Hans
    Van der Meer, Adriaan
    Nevens, Frederik
    Van Hoek, Bart
    JOURNAL OF HEPATOLOGY, 2020, 73 : S480 - S481
  • [34] Evaluation of long-term outcome in 170 patients with well-characterized autoimmune hepatitis (AIH) in a German single university center cohort
    Martens, Bjoern
    Schlosser, Beate
    Biermer, Michael
    van Boemmel, Florian
    Fueloep, Balazs
    Schott, Eckart
    Wiedenmann, Bertram
    Mueller, Tobias
    Berg, Thomas
    HEPATOLOGY, 2013, 58 : 571A - 571A
  • [35] Long-term simvastatin treatment not associated with cancer risk
    Reactions Weekly, 2004, 1017 (1) : 3 - 3
  • [36] Long-term omeprazole treatment and risk of gastric cancer
    Cammarota, G
    Cianci, R
    Gasbarrini, G
    GASTROENTEROLOGY, 2000, 119 (04) : 1176 - 1177
  • [37] Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival
    Al-Chalabi, T.
    Portmann, B. C.
    Bernal, W.
    Mcfarlane, I. G.
    Heneghan, M. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (02) : 209 - 220
  • [38] Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response
    Werner, Marten
    Wallerstedt, Sven
    Lindgren, Stefan
    Almer, Sven
    Bjornsson, Einar
    Bergquist, Annika
    Prytz, Hanne
    Sandberg-Gertzen, Hanna
    Hultcrantz, Rolf
    Sangfelt, Per
    Weiland, Ola
    Ohlsson, Bodil
    Danielsson, Ake
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (04) : 457 - 467
  • [39] Celiac Disease-Associated Autoimmune Hepatitis in Childhood: Long-Term Response to Treatment
    Nastasio, Silvia
    Sciveres, Marco
    Riva, Silvia
    Filippeschi, Irene P.
    Vajro, Pietro
    Maggiore, Giuseppe
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2013, 56 (06): : 671 - 674
  • [40] Drug withdrawal in patients with autoimmune hepatitis in long-term histological remission: A prospective observational study
    van den Brand, Floris F.
    Snijders, Romee J. A. L. M.
    de Boer, Ynto S.
    Verwer, Bart J.
    van Nieuwkerk, Carin M. J.
    Bloemena, Elisabeth
    Kuiken, Sjoerd D.
    Drenth, Joost P. H.
    Bouma, Gerd
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 90 : 30 - 36
12345